Precision medicine,Medicine,Chinese traditional,Western medicine,Integrative medicine," /> Precision medicine,Medicine,Chinese traditional,Western medicine,Integrative medicine,"/> Integration of traditional Chinese medicine and Western medicine in the era of precision medicine
Search JIM Advanced Search

Journal of Integrative Medicine ›› 2017, Vol. 15 ›› Issue (1): 1-7.doi: 10.1016/S2095-4964(17)60314-5

Special Issue: Traditional Chinese Medicine

• Editorial •     Next Articles

Integration of traditional Chinese medicine and Western medicine in the era of precision medicine

Wen-jian Wanga,b, Teng Zhangb,c   

  1. a Institute of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China 
    b Clinical Research Institute of Chinese Integrative Medicine, Shanghai Academy of Traditional Chinese Medicine,Shanghai 200437, China 
    c Yueyang Hospital of Chinese Integrative Medicine, Shanghai University of Traditional Chinese Medicine,Shanghai 200437, China
  • Received:2016-09-02 Accepted:2016-11-08 Online:2017-01-15 Published:2017-01-15
  • Contact: Prof. Wen-jian Wang; E-mail: wj6518@163.com

Precision medicine has received growing recognition from clinicians, health systems, and the pharmaceutical industry, as well as patients and policymakers, which will leave a major impact on the practice of medicine. Interestingly, traditional Chinese medicine (TCM) provides personalized medical treatment based on the theory of TCM characterized by holistic concept and pattern differentiation. This, to some extent, is similar to the personalized medical treatment of precision medicine. In China, TCM as well as Western medicine (WM) plays an important role in healthcare. In this article, the authors summarized the influence of precision medicine on current medical directions, the advantages of TCM in disease treatment, further development of precision medicine and the strategies for integration of TCM and WM under this new treatment approach. In addition, the authors discuss the perspective of precise medical diagnosis and treatment, precise prevention, and the complementary advantages of the integration of TCM and WM. Finally, the authors give their perspectives on the challenges and opportunities presented by precision medicine, in the context of further research toward the integration of TCM and WM.

Key words: Precision medicine, Medicine,Chinese traditional, Western medicine, Integrative medicine

1 Mei T, Zhang Y, Hu S, Yang HM, Zhou Y.Construction of precision medicine system and its challenges. Zhongguo Shu Zi Yi Xue.2016; 11(1): 44-48. Chinese with abstract in English.
2 Yang JF, Noffsinger A, Sreenarasimhaiah J, Yang Q.Mo1683 colorectal cancers with/without DNA mismatch repair defi ciency and tumor distribution patterns from 5 088 patients. Gastroenterology.2016; 150(4): S750-S750.
3 Yan W, Zhang A, Powell MJ.Genetic alteration and mutation profiling of circulating cell-free tumor DNA (cfDNA) for diagnosis and targeted therapy of gastrointestinal stromal tumors. Chin J Cancer.2016; 35(1): 68.
4 Liontos M, Anastasiou I, Bamias A, Dimopoulos MA.DN A damage, tumor mutational load and their impact on immune responses against cancer. Ann Transl Med. 2016; 4(14): 264.
5 Baek JH, Sun JM, Min YJ, Cho EK, Cho BC, Kim JH, Ahn MJ, Park K.Efficacy of EGFR tyrosine kinase inhibitors in patients with EG FR-mutated non-small cell lung cancer except both exon 19 deletion and exon 21 L858R: a retrospective analysis in Korea. Lung Cancer.2015; 87(2): 148-154.
6 Jang SH.Long te rm therapeutic plan for patients with nonsmall cell lung cancer harboring EGFR mutation. Tuberc Respir Dis (Seoul).2014; 76(1): 8-14.
7 Anderson WF, Rosenberg PS, Katki HA.Tr acking and evaluating molecular tumor markers with cancer registry data: HER2 and breast cancer. J Natl Cancer Inst.2014; 106(5): pii: dju093.
8 Wong IO, Schooling CM, Cowling BJ, Leung GM.Br east cancer incidence and mortality in a transitioning Chinese population: current and future trends. Br J Cancer.2015; 112(1): 167-170.
9 Recondo G Jr, de la Vega M, Galanternik F, Díaz-Cantón E, Leone BA, Leone JP. Nove l approaches to target HER2- positive breast cancer: trastuzumab emtansine.Cancer Manag Res. 2016; 8: 57-65.
10 Meers C, Keskin H, Storici F.DNA repair by RNA: templated, or not templated, that is the question. DNA Repair (Amst).2016; 44: 17-21.
11 Marshall E.Huma n genome 10th anniversary. Waiting for the revolution.Science. 2011; 331(6017): 526-529.
12 Editorial. Best is yet to come.Nature. 2011; 470(7333): 140.
13 Check Hayden E.Huma n genome at ten: life is complicated. Nature.2010; 464(7289): 664-667.
14 National Research Council.Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. Washington DC: National Academies Press. 2011.
15 Wu JR.Precision medicine based on systems biology. Sheng Ming Ke Xue.2015; 27(5): 558-563. Chinese with abstract in English.
16 16 Luo CS, Liu XJ. The problems we faced in development of precision medicine. (2015-06-10) [2016-08-10]. . The problems we faced in development of precision medicine. (2015-06-10) [2016-08-10]. http:// h.wokeji.com/jbsj/bb/201506/t20150610_1268749.shtml.
17 Yang GZ, Su XH, Wu XF, Dai XJ, Yang LY, Pan CZ.Association of single nucleotide polymorphisms in the proximal promoter region of the adiponectin gene with TCM syndromes in patients with type 2 diabetes. Guo Ji Zhong Yi Zhong Yao Za Zhi.2016; 38(3): 204-208. Chinese with abstract in English.
18 Liu Q, Ling JY, Li XD, Zhang CZ, Song QL, Tan J, Huang J, Peng XM, Wang JP, Wu JH.Associations of rs3820998 polymorphism in TANK gene with syndrome types of TCM of hepatitis B related cirrhosis. Zhong Xi Yi Jie He Gan Bing Za Zhi.2013; 23(4): 241-244. Chinese with abstract in English.
19 Shen ZY, Huang JH, Chen WH. Comparison of gene expression profiles between rats of Shen deficiency syndrome and Shen-yang defi ciency syndrome differentiated according to therapeutic effi cacy of drugs used. Zhongguo Zhong Xi Yi Jie He Za Zhi.2007; 27(2): 135-137. Chinese with abstract in English.
20 Fan X, Shi M, Wang Y, Liang Q, Luo G.Tran scriptional profi ling analysis of HMP-treated rats with experimentally induced myocardial infarction. J Ethnopharmacol.2011; 137(1): 199-204.
21 Zhu H, Luo XP, Wang LJ, Li Y, Shi HM, Fan WH, Dai HR.Evaluation on clinical effect of long-term Shexiang Baoxin pill administration for treatment of coronary heart disease. Zhongguo Zhong Xi Yi Jie He Za Zhi.2010; 30(5): 474-477. Chinese with abstract in English.
22 Luo XP, Li Y, Fan WJ, Zhang GF, Zhang J, Shi HM, Wang CP, Wang SY, Dai RH.Experimental study on reducing effect of Shexiang Baoxin pill from damage of arterial wall caused by hyperlipemia. Zhongguo Zhong Xi Yi Jie He Za Zhi.1998; 18(8): 486-489. Chinese with abstract in English.
23 Zhang RX, Liu HJ. Treatment of unstable angina pectoris with Shexiang Baoxin pills combined with clopidogrel. Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi. 2009; 7(9):1114-1115. Chinese.
24 Gan L, Ling YJ, Zhu LP.Experience of the treatment of mild hypertension with increased low-density lipoprotein cholesterol. Zhong Cheng Yao.2005; 27(5): 635-637. Chinese.
25 Song KY, Wei YJ, Li LT.Effects of Shexiang Baoxin pills on coronary flow reserve in patients with slow coronary flow. Changchun Zhong Yi Yao Da Xue Xue Bao.2011; 27(5): 720-722. Chinese.
26 Shen W, Fan WH, Shi HM, Li Y, Luo XP, Zhang XL, Zhu J, Jin B, Li J, Pan JJ. Effects of Shexiang Baoxin pill on angiogenesis in atherosclerosis plaque and ischemic myocardium. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2010; 30(12):1284-1287. Chinese with abstract in English.
27 Chen Y, Fu DY, Chen Y, He YM, Fu XD, Xu YQ, Liu Y, Feng XT, Zhang T, Wang WJ.Effe cts of Chinese herbal medicine Yiqi Huaju Formula on hypertensive patients with metabolic syndrome: a randomized, placebo-controlled trial. J Integr Med. 2013; 11(3): 184-194.
28 Wang TZ, Chen Y, He YM, Fu XD, Wang Y, Xu YQ, Yang HJ, Xue HL, Liu Y, Feng XT, Zhang T, Wang WJ.Effe cts of Chinese herbal medicine Yiqi Huaju Qingli Formula in metabolic syndrome patients with microalbuminuria: a randomized placebo-controlled trial. J Integr Med. 2013; 11(3): 175-183.
29 Zhang Z, Xue HL, Liu Y, Wang WJ.Yi-Qi-Zeng-Min-Tang, a Ch inese medicine, ameliorates insulin resistance in type 2 diabetic rats. World J Gastroenterol.2011; 17(8): 987-995.
30 Feng XT, Wang TZ, Leng J, Chen Y, Liu JB, Liu Y, Wang WJ.Palm itate contributes to insulin resistance through down-regulation of the Src-mediated phosphorylation of Akt in C2C12 myotubes. Biosci Biotechnol Biochem.2012; 76(7): 1356-1361.
31 Feng X, Wang W, Liu J, Liu Y.β-Arrestins: multi functional signaling adaptors in type 2 diabetes. Mol Biol Rep.2011; 38(4): 2517-2528.
32 Ya ng Q, Jia C, Wang P, Xiong M, Cui J, Li L, Wang W, Wu Q, Chen Y, Zhang T. MicroR NA-505 identified from patients with essential hypertension impairs endothelial cell migration and tube formation.Int J Cardiol. 2014; 177(3): 925-934.
33 Ga o S, Wang P, Hua Y, Xi H, Meng Z, Liu T, Chen Z, Liu L. ROR fu nctions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer.Oncotarget. 2016; 7(2): 1608-1618.
34 Hu J, Qiu M, Jiang F, Zhang S, Yang X, Wang J, Xu L, Yin R.MiR-14 5 regulates cancer stem-like properties and epithelial-to-mesenchymal transition in lung adenocarcinoma-initiating cells. Tumour Biol.2014; 35(9): 8953-8961.
35 Yi JH, Shi WD, Liu LM.The recipe of Qingyi Huaji in treating advanced pancreatic cancer against expression of MMP-2. Zhong Yi Lin Chuang Yan Jiu.2014; 6(7): 30-32. Chinese with abstract in English.
36 Zhang JJ, Chen Z, Shi WD, Zhu XY, Liu LM.Effect of Qingyi Huaji Formula on serum immunosuppressive factors and immune function of splenic lymphocytes in mice with pancreatic cancer. Zhongguo Shi Yan Fang Ji Xue Za Zhi.2008; 14(6): 49-51. Chinese with abstract in English.
[1] Brody Slostad, Tejinder Khalsa, Kathleen Young, Hildalicia Guerra, Anjali Bhagra. A case-based approach to integrative medicine for cardiovascular disease prevention. Journal of Integrative Medicine, 2020, 18(2): 159-162.
[2] Wen Qiang Lee, Jeremy Teoh, Pei Zheng Kenneth Lee, Zhi Xiong Gerard Low, Xueling Sim, Foong Fong Mary Chong, Norbert Ludwig Wagner. Factors influencing communication of traditional Chinese medicine use between patients and doctors: a multisite cross-sectional study. Journal of Integrative Medicine, 2019, 17(6): 396-403.
[3] Mohammad Hossein Ayati, Ata Pourabbasi, Nazli Namazi, Arman Zargaran, Zahra Kheiry, Amir Hooman Kazemi, Bagher Larijani. The necessity for integrating traditional, complementary, and alternative medicine into medical education curricula in Iran. Journal of Integrative Medicine, 2019, 17(4): 296-301.
[4] Mikhail Teppone. Medicine has always been “Modern” and “Scientific” from ancient times to the present day. Journal of Integrative Medicine, 2019, 17(4): 229-237.
[5] Tamer Aboushanab, Mohamed Khalil, YaserAl Ahmari. The present state of complementary medicine regulation in Saudi Arabia. Journal of Integrative Medicine, 2019, 17(3): 147-149.
[6] Hanae Naceiri Mrabti, Nidal Jaradat, Mohamed Reda Kachmar, Abdelaziz Ed-Dra, Abdelilah Ouahbi, Yahia Cherrah, Moulay El Abbes Faouzi. Integrative herbal treatments of diabetes in Beni Mellal region of Morocco. Journal of Integrative Medicine, 2019, 17(2): 93-99.
[7] Fung-Kei Cheng. An overview of the contribution of acupuncture to thyroid disorders. Journal of Integrative Medicine, 2018, 16(6): 375-383.
[8] Chang-quan Ling, Jia Fan, Hong-sheng Lin, Feng Shen, Zhen-ye Xu, Li-zhu Lin, Shu-kui Qin, Wei-ping Zhou, Xiao-feng Zhai, Bai Li, Qing-hui Zhou, on behalf of the Chinese Integrative Therapy of Primary Liver Cancer Working Group. Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine. Journal of Integrative Medicine, 2018, 16(4): 236-248.
[9] Nian Huang. Integrative medicine is an evolving field and the future of healthcare: A summary of the 2017 Integrative Medicine Shanghai Forum. Journal of Integrative Medicine, 2018, 16(2): 71-71.
[10] Saswati Mahapatra, Anjali Bhagra, Bisrat Fekadu, Zhuo Li, Brent A. Bauer, Dietlind L. Wahner-Roedler. Incorporation of integrative medicine education into undergraduate medical education: A longitudinal study. Journal of Integrative Medicine, 2017, 15(6): 442-449.
[11] Xuan Liu, Li-juan Xiu, Jian-peng Jiao, Jing Zhao, Ying Zhao, Ye Lu, Jun Shi, Yong-jin Li, Min Ye, Yu-fang Gu, Xiao-wei Wang, Jing-yu Xu, Ci-an Zhang, Yong-ying Liu, Yun Luo, Xiao-qiang Yue. Traditional Chinese medicine integrated with chemotherapy for stage IV non-surgical gastric cancer: A retrospective clinical analysis. Journal of Integrative Medicine, 2017, 15(6): 469-475.
[12] Andrian Liem, Kuncoro Dewi Rahmawati. The meaning of complementary, alternative and traditional medicine among the Indonesian psychology community: A pilot study. Journal of Integrative Medicine, 2017, 15(4): 288-294.
[13] Jin Yu, Chao-qin Yu, Qi Cao, Li Wang, Wen-jun Wang, Li-rong Zhou, Jing Li, Qiao-hong Qian. Consensus on the integrated traditional Chinese and Western medicine criteria of diagnostic classification in polycystic ovary syndrome (draft). Journal of Integrative Medicine, 2017, 15(2): 102-109.
[14] Razak Mohammed Gyasi, Adjoa Afriyie Poku, Simon Boateng, Padmore Adusei Amoah, Alhassan Abdul Mumin, Jacob Obodai, Williams Agyemang-Duah. Integration for coexistence? Implementation of intercultural health care policy in Ghana from the perspective of service users and providers. Journal of Integrative Medicine, 2017, 15(1): 44-55.
[15] Negoslav P. Ostojić, Silvia Saxer. Policies towards implementation of positive changes and the introduction of integrated health care for health systems. Journal of Integrative Medicine, 2016, 14(6): 409-411.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[2] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. An explanation on "guiding principles of clinical research on mild cognitive impairment (protocol)". Journal of Chinese Integrative Medicine, 2008, 6(1): 15-21
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[5] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[6] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[7] Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[8] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[9] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[10] Hai-feng Wei, Bai-liu Ya, Ling Zhao, Cui-fei Ye, Li Zhang, Lin Li. Evaluation of tongue manifestation of blood stasis syndrome and its relationship with blood rheological disorder in a rat model of transient brain ischemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 73-76